{"id":282,"date":"2026-07-20T11:44:14","date_gmt":"2026-07-20T15:44:14","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/?p=282"},"modified":"2026-07-20T11:44:15","modified_gmt":"2026-07-20T15:44:15","slug":"pharmacy-benefit-manager-reaches-settlement-ftc-requiring-changes-drug-pricing-practices","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/2026\/07\/20\/pharmacy-benefit-manager-reaches-settlement-ftc-requiring-changes-drug-pricing-practices\/","title":{"rendered":"Pharmacy Benefit Manager Reaches Settlement with FTC Requiring Changes to Drug Pricing and Practices"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">By <a href=\"https:\/\/www.duanemorris.com\/attorneys\/seanpmcconnell.html\">Sean P. McConnell<\/a>,\u00a0<a href=\"https:\/\/www.duanemorris.com\/attorneys\/jonathanlswichar.html\">Jonathan L. Swichar<\/a>,\u00a0<a href=\"https:\/\/www.duanemorris.com\/attorneys\/bradleyawasser.html\">Bradley A. Wasser<\/a> and <a href=\"https:\/\/www.duanemorris.com\/attorneys\/ninakalandadze.html\">Nina Kalandadze<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Last week, the Federal Trade Commission announced a settlement with Caremark Rx LLC and Zinc Health Services LLC in the agency\u2019s administrative case against the nation\u2019s three largest pharmacy benefit managers. Under the terms of the settlement, Caremark agreed to make certain structural changes to its pharmaceutical pricing and reimbursement practices. The Caremark settlement has distinct implications for participants across the pharmaceutical supply chain, and each should take specific steps to evaluate exposure and mitigate risk.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read the full <em><a href=\"https:\/\/www.duanemorris.com\/alerts\/pharmacy_benefit_manager_reaches_settlement_ftc_requiring_changes_drug_pricing_practices_0726.html\">Alert<\/a><\/em> on the Duane Morris LLP website. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Sean P. McConnell,\u00a0Jonathan L. Swichar,\u00a0Bradley A. Wasser and Nina Kalandadze Last week, the Federal Trade Commission announced a settlement with Caremark Rx LLC and Zinc Health Services LLC in the agency\u2019s administrative case against the nation\u2019s three largest pharmacy benefit managers. Under the terms of the settlement, Caremark agreed to make certain structural changes &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/antitrustlaw\/2026\/07\/20\/pharmacy-benefit-manager-reaches-settlement-ftc-requiring-changes-drug-pricing-practices\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pharmacy Benefit Manager Reaches Settlement with FTC Requiring Changes to Drug Pricing and Practices&#8221;<\/span><\/a><\/p>\n","protected":false},"author":660,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"ppma_author":[9],"class_list":["post-282","post","type-post","status-publish","format-standard","hentry","category-general"],"authors":[{"term_id":9,"user_id":660,"is_guest":0,"slug":"spmcconnell","display_name":"Sean P. McConnell","avatar_url":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-content\/uploads\/sites\/68\/2025\/10\/mcconnellsean-100x100.jpg","author_category":"","last_name":"McConnell","first_name":"Sean","job_title":"","user_url":"https:\/\/www.duanemorris.com\/attorneys\/seanpmcconnell.html","description":"<A HREF=\"https:\/\/www.duanemorris.com\/attorneys\/seanpmcconnell.html\">Read Sean's Bio<\/a>"}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/users\/660"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/comments?post=282"}],"version-history":[{"count":1,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/282\/revisions"}],"predecessor-version":[{"id":283,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/282\/revisions\/283"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/media?parent=282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/categories?post=282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/tags?post=282"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/ppma_author?post=282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}